title: How should we measure the impact of chronic pain? Limitations of utility measurement using the EQ-5D and SF-6D.
authors.affiliation: NHMRC Clinical Trials Centre and School of Public Health, University of Sydney, 92-94 Parramatta Road, Camperdown, NSW 1450, Australia.
authors.forename: Deborah J
authors.initials: DJ
authors.lastname: Schofield
mesh_terms: D059350:Chronic Pain / Q000175:diagnosis*; D017281:Cost of Illness; D005260:Female; D006801:Humans; D008297:Male; D009437:Neuralgia / Q000175:diagnosis*; D011788:Quality of Life
references.citation: Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271-292.
references.citation: Brazier J, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42:851-859.
references.citation: Brazier J, Roberts J, Tsuchiya A, Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 2004;13:873-884.
references.citation: Krahn M, Ritvo P, Irvine J, Tomlinson G, Bremner K, Bezjak A, Trachtenberg J, Naglie G. Patient and community preferences for outcomes in prostate cancer: implications for clinical policy. Med Care. 2003;41:153-164.
references.citation: Postulart D, Adang E. Response shift and adaptation in chronically iii patients. Med Decis Making. 2000;20:186-193.
references.citation: Tinelli M, Seymour J, McNamee P, Scott A, Tinelli M. Shedding new light onto the ceiling and floor? A quantile regression approach to compare EQ-5D and SF-6D responses. Health Econ. 2010;19:683-696.
references.citation: Torrance G. Measurement of health state utilities for economic appraisal. J Health Econ. 1986;5:1-30.
references.citation: Torrance N, Lawson KD, Afolabi E, Bennett MI, Serpell MG, Dunn KM, Smith BH. Estimating the burden of disease in chronic pain with and without neuropathic characteristics: Does the choice between the EQ-5D and SF-6D matter? PAIN® 2014;155:1996–2004.
references.citation: van Stel HF, Buskens E. Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease. Health Qual Life Outcomes. 2006;4:20.